Overview of Guarantees
Shanghai Xuerong Biotechnology Co., Ltd. (hereinafter referred to as "the Company") held the 25th meeting of the 5th Board of Directors and the 15th meeting of the 5th Supervisory Board on April 25, 2025, and convened the 2024 Annual General Meeting of Shareholders on May 23, 2025, to review and approve the proposal on the estimated guarantee limit for 2025. To meet the operational and business development needs of the Company and its subsidiaries, and to ensure smooth cash flow, the Company estimates that it will provide a total guarantee limit of no more than RMB 2.09 billion (including the principal) for subsidiaries applying for financing from banks or other financial institutions in 2025, under the premise of ensuring standardized operations and controllable risks. Among this, the guarantee limit for subsidiaries with a debt-to-asset ratio below 70% is RMB 890 million (including the principal), and for those above 70%, it is RMB 1.2 billion (including the principal). The validity period of the guarantee limit is from the date of approval by the Company's 2024 Annual General Meeting of Shareholders until the date of the 2025 Annual General Meeting of Shareholders, and the above guarantee limit can be used repeatedly within the validity period. For specific details, please refer to the announcement published by the Company on the designated information disclosure website of the China Securities Regulatory Commission, "Announcement on Estimated Guarantee Limit for 2025" (Announcement No. 2025-048).